SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-19-046144
Filing Date
2019-02-21
Accepted
2019-02-21 06:53:07
Documents
4
Group Members
CASCADE MERGER SUB INC.MERCK SHARP & DOHME CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d689026dsctoc.htm SC TO-C 17138
2 EX-99.1 d689026dex991.htm EX-99.1 18022
3 GRAPHIC g689026g0220191334648.jpg GRAPHIC 3507
4 GRAPHIC g689026g0220191334753.jpg GRAPHIC 4418
  Complete submission text file 0001193125-19-046144.txt   48421
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filed by) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88256 | Film No.: 19620467
SIC: 2834 Pharmaceutical Preparations